摘要
近年来的流行病学调查数据显示,肺癌已经成为我国癌症发病率和死亡率上升最快的恶性肿瘤。目前在我国,尤其是城市地区,肺癌的发病率和死亡率已占首位。而随着人口预期寿命的延长,我国正逐步进入老龄化社会,
出处
《中华临床医师杂志(电子版)》
CAS
2013年第21期4-6,共3页
Chinese Journal of Clinicians(Electronic Edition)
参考文献12
-
1Henschke CI,McCauley DI,Yankelevitz DF. Early Lung Cancer Action Project:overall design and findings from baseline screening[J].{H}LANCET,1999.99-105.
-
2Yu IT,Tse LA,Leung CC. Lung cancer mortality among silicotic workers in Hong Kong--no evidence for a link[J].{H}ANNALS OF ONCOLOGY,2007.1056-1063.
-
3Jang TW,Oak CH,Chun BK. Detection of pre-invasive endobronchial tumors with D-light/autofluorescence system[J].{H}Journal of Korean Medical Science,2006.242-246.
-
4The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer[J].{H}JOURNAL OF THE NATIONAL CANCER INSTITUTE,1999.66-72.
-
5Kudoh S,Takeda K,Nakagawa K. Phase Ⅲ study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer:results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)[J].{H}Journal of Clinical Oncology,2006.3657-3663.
-
6Frasci G,Lorusso V,Panza N. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer[J].{H}Journal of Clinical Oncology,2000.2529-2536.
-
7Gridelli C,Perrone F,Gallo C. Chemotherapy for elderly patients with advanced non-small-cell lung cancer:the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase Ⅲ randomized trial[J].{H}JOURNAL OF THE NATIONAL CANCER INSTITUTE,2003.362-372.
-
8Quoix E,Zalcman G,Oster JP. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer:IFCT-0501 randomised,phase 3 trial[J].{H}LANCET,2011.1079-1088.
-
9Crino L,Cappuzzo F,Zatloukal P. Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE):a randomized,phase Ⅱ study[J].{H}Journal of Clinical Oncology,2008.4253-4260.
-
10Jackman DM,Yeap BY,Lindeman NI. Phase Ⅱ clinical trial of chemotherapy-naive patients》or=70 years of age treated with erlotinib for advanced non-small-cell lung cancer[J].{H}Journal of Clinical Oncology,2007.760-766.
同被引文献30
-
1Owonikoko TK, Ragin CC, Belmfi CP, et al. Lung cancer in elder- ly patients: an mlalysis of the surveillance, epidenfiology, and end results database[J]. Clin Oncol, 2007, 25(35):5570-5577.
-
2Nugent WC, Edney MT, Hammerness PG, et al. Non small cell lung cancer at the extremes of age:impact on diagnosis and treat- ment[J]. Ann Thorac Surg, 1997, 63(1):193-197.
-
3Ginsberg RJ, Rubinstehl LV. Randomized trial of Iobectomy ver- sus limited resection for YINo nml-small cell lung cancer:Lung Cancer Study Group[J]. Ann Thorae Surg, 1995, 60(3):615-622.
-
4Quoix E, Zalcman G, OsterJP, et al. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial[J]. Lancet, 2011, 378(9796):1079-1088.
-
5Whitson BA, Groth SS, Andrade RS, et al. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis[J]. Ann Thorac Surg, 2011, 92(19):43-50.
-
6Sirbu H, Schreiner W, Dalichan H, et al. Surgery for non-small cell carcinoma in geriatric patients: 15-year experience[J]. Asian Cardiovasc Thorac Ann, 2005, 13 (4) :330-336.
-
7Schuchert MJ, Kilic A, Pennathur A, et al. Oncologic outcomes af- surgical resection of subcentimeter non-small cell lung cancer [J]. Ann Thorac Surg, 2011, 91(6):1681-1687.
-
8Rami-Porta R, Ball D, CrowleyJ, et al. The IASLC Lung Cancer Staging Project proposals for the revision of the T descriptors in the forthcoming(seventh)edition of the TNM classification for lung cancer[J]. Thoracic Oncol, 2007, 2(7):593-602.
-
9Yendamuri S, Shanna R, Demmy M, et al. Temporal trends in out- comes following sublobar and lobar resections for small (≤ 2 cm) non-small cel/lung cancers-a Surveillance Epidemiology End Re- sults database analysis[J]. Surg Res, 2013, 183(1):27-32.
-
10Fan J, Wang L, Jiang GN, et al. Sublobectomy versus lobectomy for stage I non-smaLl-cell lung cancer, a meta-analysis of pub- lished studies[J]. Ann Surg Oncol, 2012, 19(2):661-668.
引证文献4
-
1张秀强,岳东升,王长利.两种术式治疗老年Ⅰ期非小细胞肺癌的预后分析[J].中国肿瘤临床,2015,42(7):386-391. 被引量:14
-
2李春刚.肺癌的早期诊断[J].中国医疗器械信息,2015,21(01Z):325-325.
-
3石睿.老年肺部疾病患者PCT及hsTnT检测结果分析[J].基层医学论坛,2017,21(13):1667-1668.
-
4汪静.多层CT在肺内结节影像诊断与价值分析[J].航空航天医学杂志,2018,29(7):782-783. 被引量:1
二级引证文献15
-
1赵静,武二伟,邢爱民,冯艳亮,张念波,王琰.119例局部晚期非小细胞肺癌放化疗后预后分析[J].临床肺科杂志,2017,22(8):1481-1485. 被引量:22
-
2贾志艳.Ⅲ期非小细胞肺癌应用同步放化疗治疗效果研究[J].世界复合医学,2017,3(3):36-38. 被引量:4
-
3陈文,李星,张璐.胸腔镜下肺楔形切除术治疗老年Ⅰ期非小细胞肺癌的疗效分析[J].河北医科大学学报,2017,38(11):1330-1333. 被引量:13
-
4吉红波.肺叶切除术和局限性切除术对老年Ⅰ期非小细胞肺癌患者的预后影响[J].实用癌症杂志,2018,33(2):268-272. 被引量:5
-
5许建强,曹念,代阅,冯娟,刘丽华.索拉非尼对非小细胞肺癌H460与A549细胞株的抑制作用及其机制[J].肿瘤药学,2018,8(1):26-30. 被引量:1
-
6李志国,马会,石晓鹏.电视胸腔镜下亚肺叶切除治疗高龄非小细胞肺癌患者的近期疗效及远期预后生存分析[J].河北医药,2018,40(17):2650-2653. 被引量:16
-
7余忠林,袁德武.全胸腔镜肺叶切除术治疗高龄非小细胞肺癌近期效果及远期预后生存分析[J].解放军医药杂志,2018,30(1):34-37. 被引量:25
-
8陈涛,李向成,廉彧,汲克强,华军,马路遥.凝血功能对胸腔镜手术治疗非小细胞肺癌疗效评估及预后预测的临床价值分析[J].现代生物医学进展,2020,20(16):3082-3086. 被引量:7
-
9陈新富,刘宁.肺楔形切除治疗Ⅰ期高龄非小细胞肺癌的疗效及其预后危险因素分析[J].中外医疗,2021,40(35):8-12.
-
10鲁达,杨金生,杜晚楠.64排螺旋CT容积扫描对孤立肺内小结节鉴别诊断的价值研究[J].中国冶金工业医学杂志,2022,39(1):8-9. 被引量:3
-
1赵晓敏,李云涛,季国忠.结直肠癌筛查现状与进展[J].中国临床研究,2016,29(6):838-841. 被引量:23
-
2李喜成,李夙恩.多发性骨髓瘤66例临床分析[J].中外健康文摘,2009,6(05X):43-44.
-
3邱朔.基层医院老年全胃切除术47例治疗体会[J].中华腹部疾病杂志,2005,5(1):43-45.
-
4忙尼沙汗.阿不都,玛依努尔.艾力.老年进展期消化道恶性肿瘤21例临床分析[J].新疆医科大学学报,2007,30(9):1030-1031.
-
5李程.58例老年性乳腺癌的临床分析[J].广西医学,2006,28(12):1971-1972.
-
6孙宏劭,杨艳.替吉奥联合奥沙利铂治疗老年人晚期胃癌疗效观察[J].武警医学,2012,23(3):253-254. 被引量:3
-
7王金龙.高龄大肠癌致急性肠梗阻42例患者的围手术期处理[J].中国现代普通外科进展,2011,14(10):783-783.
-
8孙伟,董海丽.替吉奥胶囊治疗老年胃癌疗效观察[J].实用医技杂志,2013,20(12):1336-1337.
-
9肿瘤学[J].国外科技资料目录(医药卫生),1998(12):101-102.
-
10义军.肿瘤患者手中的金盾[J].现代养生,2012,0(9X):69-70.